Increased β-amyloid accumulation may be linked to Alzheimer's dementia risk in oldest of the old

A new study indicates that severity of amyloid deposition in the brain -; not just age -; may be key to determining who will benefit from new anti-amyloid therapies to delay the progression of Alzheimer's disease.

Related Keywords

United States ,Australia ,American ,Australian ,Yuefang Chan ,Howard Aizenstein ,Hanne Cohen ,Chester Mathis ,Brian Lopresti ,Victor Villemagne ,Milos Ikonomovic ,William Klunk ,Oscar Lopez ,Tharick Pascoal ,Ilyas Kamboh ,Beth Snitz ,National Institutes Of Health Center ,National Institute On ,University Of Pittsburgh ,American Academy Of Neurology ,Integrative Health ,Office Of Dietary Supplements ,Pitt Alzheimer Disease Research Center ,American Academy ,Australian Imaging ,Disease Research ,National Institutes ,Health National Center ,Dietary Supplements ,National Institute ,Dementia ,Lzheimer 39s Disease ,Rain ,Maging ,Eurology ,Pathology ,Mh ,Research ,